Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$357K Buy
3,932
+662
+20% +$60.4K 0.05% 147
2026
Q1
$336K Buy
3,270
+31
+1% +$3.5K 0.06% 136
2025
Q4
$406K Buy
3,239
+93
+3% +$11.8K 0.08% 113
2025
Q3
$421K Sell
3,146
-202
-6% -$26.5K 0.09% 111
2025
Q2
$455K Buy
3,348
+1,120
+50% +$148K 0.1% 105
2025
Q1
$296K Buy
2,228
+73
+3% +$9.29K 0.08% 121
2024
Q4
$244K Buy
2,155
+198
+10% +$22.9K 0.07% 140
2024
Q3
$223K Buy
+1,957
New +$215K 0.07% 148
2024
Q2
Sell
-1,821
Closed -$207K 154
2024
Q1
$207K Buy
+1,821
New +$209K 0.07% 148

Other funds holding ABT

Verum Partners's ABT Position: Q2 2026 in Review

Verum Partners increased its Abbott (ABT) stake by 20% in Q2 2026, buying an estimated $60.4K and bringing the position to 3,932 shares worth $357K. The position accounts for 0.05% of the portfolio, ranked #147.

Verum Partners first reported a position in ABT in Q1 2024 and has held it in 9 quarters since. The position peaked at $455K in Q2 2025. 2,964 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Verum Partners held 3,932 shares of Abbott worth $357K as of Q2 2026.
  • Verum Partners bought 662 Abbott shares in Q2 2026, an estimated $60.4K.
  • Abbott made up 0.05% of Verum Partners's portfolio in Q2 2026, its #147 holding.
  • Verum Partners first reported a position in Abbott in Q1 2024 and has held it in 9 quarters since.
  • Verum Partners's Abbott position peaked at $455K in Q2 2025.
  • 2,964 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Verum Partners's 13F filing for Q2 2026, filed 22 Jul 2026.